Cochlear shares rise amid mixed financial results and analyst ratings

Cochlear Ltd shares have seen a recent upward trend, rising approximately 9% over a one-week period. Despite this momentum, the stock remains significantly lower than its levels from one year ago.

Financial reports for the quarter ending June 30, 2026, showed revenue of 1.16 billion AUD, a slight decrease from the 1.19 billion AUD reported in the previous year's corresponding quarter. The company also reported a GAAP net loss of 14.20 million AUD, compared to a net profit of 183.80 million AUD in the prior year's quarter.

Market analysts remain largely cautious, with a majority of brokers maintaining a ‘hold’ rating. UBS confirmed a ‘hold’ rating with a price target of 135.00 AUD, while average target prices from various analysts range between approximately 131.37 AUD and 138.53 AUD. However, some bullish projections suggest the stock could potentially reach 165.00 AUD over the next 12 months.